Lobbying registration dated 2026-03-04
Registrant: Viktoria Friedrich
Client: Bayer Inc.
Targeted institutions:
Environment and Climate Change Canada (ECCC)
Employment and Social Development Canada (ESDC)
Finance Canada (FIN)
Canadian Institutes of Health Research (CIHR)
Prime Minister's Office (PMO)
National Research Council (NRC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Invest in Canada Hub
Canada Revenue Agency (CRA)
Canadian Food Inspection Agency (CFIA)
Public Health Agency of Canada (PHAC)
Patented Medicine Prices Review Board (PMPRB)
Global Affairs Canada (GAC)
Privy Council Office (PCO)
Senate of Canada
Health Canada (HC)
Legislative bills: S-243
Government funding received:
Lobbying activity details:
Communicating with government officials on Bill S-243, An Act to establish a national framework for women’s health in Canada. Providing guidance, subject matter expertise and relevant information to help inform future policy development.
Communicating, in general, with officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy and health of Canadians.
Advocacy as it relates to the US Administration’s Most Favored Nation drug pricing policy and its potential impact for Canada
Domestic and international trade policies in support of the biopharmaceutical industry, including competitive and predictable intellectual property protection, product regulation and patient access to medicines.
Communicating with government officials on policies and/or programs that support life science research and development conducted in Canada, including manufacturing and workforce development, including measures pertaining to Canada’s Biomanufacturing and Life Sciences Strategy.